Table 3.
N | ALF | LC |
---|---|---|
5 | 22 | |
Response to vaccination (good/poor responders) | 5/0 | 9/13 |
Number of vaccinations require before ceasing HBIg treatment | 4 (2.5–5) | 19 (11.5–30) |
HBIg Hepatitis B immunoglobulin
N | ALF | LC |
---|---|---|
5 | 22 | |
Response to vaccination (good/poor responders) | 5/0 | 9/13 |
Number of vaccinations require before ceasing HBIg treatment | 4 (2.5–5) | 19 (11.5–30) |
HBIg Hepatitis B immunoglobulin